Health

Results: 181-192 of 5143

PR Newswire associated0

Jazz Pharmaceuticals to Participate in the 24th Annual Needham Virtual Healthcare Conference

PR Newswire associated0

THERME GROUP ANNOUNCES DALLAS AS FIRST LOCATION FOR ITS NEW U.S. CONCEPT

Business Wire logo

Yokohama to Host WCN’26: The World Congress of Nephrology Returns to Japan After 36 Years

PR Newswire associated0

Turn Biotechnologies Acquires ARMMs Vesicular Technology to Increase Access to Tissue Targets for its Epigenetic Reprogramming Therapies

UK Medicines and Healthcare Products Regulatory Agency has Validated and Accepted the Marketing Authorization Application for ADL-018, a Proposed Biosimilar of Xolair® (omalizumab)

Lundbeck held its Annual General Meeting on 26 March 2025 at the company's registered office

Business Wire logo

LivaNova to Announce First-Quarter 2025 Results

Business Wire logo

Areteia Therapeutics Announces Appointments of Donald J. Hayden, Jr. and Ian F. Smith to Its Board of Directors

VPZ - The Vaping Specialist

MPs Urged To Vote Responsibly On Tobacco and Vapes Bill 3rd Reading

PR Newswire associated0

SIBIONICS GS3: The World's Thinnest CGM Debuts at ATTD 2025

Procare Health released results from their latest clinical trial, Paloma 2, confirming the efficacy of Papilocare®, a vaginal gel designed to repair low-grade cervical lesions and to clear Human Papillomavirus (HPV)

NEURIM PHARMACEUTICALS RECEIVES EUROPEAN MARKETING AUTHORIZATION FOR PEDIATRIC PROLONGED-RELEASE MELATONIN (SLENYTO®) FOR THE TREATMENT OF INSOMNIA IN CHILDREN WITH ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD)